{
  "1": [
    [
      ""
    ]
  ],
  "2": [
    [
      ""
    ]
  ],
  "ipo_details": [
    [
      "IPO Date",
      "February 10, 2025 to February 12, 2025"
    ],
    [
      "Listing Date",
      "February 17, 2025"
    ],
    [
      "Face Value",
      "₹10per share"
    ],
    [
      "Issue Price",
      "₹159 per share"
    ],
    [
      "Lot Size",
      "800 Shares"
    ],
    [
      "Sale Type",
      "Fresh Capital-cum-Offer for Sale"
    ],
    [
      "Total Issue Size",
      "67,52,000shares(aggregating up to ₹107.36Cr)"
    ],
    [
      "Reserved forMarket Maker",
      "3,39,200shares(aggregating up to ₹5.39Cr)R.K.Stock Holding Pvt.Ltd."
    ],
    [
      "Fresh Issue(Ex Market Maker)",
      "41,12,864shares(aggregating up to ₹65.39Cr)"
    ],
    [
      "Offer for Sale",
      "22,99,936shares of ₹10(aggregating up to ₹36.57Cr)"
    ],
    [
      "Net Offered to Public",
      "64,12,800shares(aggregating up to ₹101.96Cr)"
    ],
    [
      "Employee Discount",
      "₹15.00"
    ],
    [
      "Issue Type",
      "BookbuildingIPO"
    ],
    [
      "Listing At",
      "NSE SME"
    ],
    [
      "Share Holding Pre Issue",
      "2,00,00,000shares"
    ],
    [
      "Share Holding Post Issue",
      "2,44,52,064shares"
    ]
  ],
  "reservation": [
    {
      "Investor Category": "Market Maker Shares Offered",
      "Shares Offered": "3,39,200 (5.02%)"
    },
    {
      "Investor Category": "QIB Shares Offered",
      "Shares Offered": "30,82,400 (45.65%)"
    },
    {
      "Investor Category": "− Anchor Investor Shares Offered",
      "Shares Offered": "18,48,800 (27.38%)"
    },
    {
      "Investor Category": "− QIB (Ex. Anchor) Shares Offered",
      "Shares Offered": "12,33,600 (18.27%)"
    },
    {
      "Investor Category": "NII (HNI) Shares Offered",
      "Shares Offered": "9,25,600 (13.71%)"
    },
    {
      "Investor Category": "Retail Shares Offered",
      "Shares Offered": "21,59,200 (31.98%)"
    },
    {
      "Investor Category": "Employee Shares Offered",
      "Shares Offered": "2,45,600 (3.64%)"
    },
    {
      "Investor Category": "Total Shares Offered",
      "Shares Offered": "67,52,000 (100.00%)"
    }
  ],
  "5": [
    {
      "Application Category": "Only RII",
      "Maximum Bidding Limits": "Up to Rs 2 Lakhs",
      "Bidding at Cut-off Price Allowed": "Yes"
    },
    {
      "Application Category": "Only NII",
      "Maximum Bidding Limits": "Above Rs 2 Lakhs",
      "Bidding at Cut-off Price Allowed": "No"
    },
    {
      "Application Category": "Only employee",
      "Maximum Bidding Limits": "Up to Rs 5 Lakhs",
      "Bidding at Cut-off Price Allowed": "Yes"
    },
    {
      "Application Category": "Employee + RII/NII",
      "Maximum Bidding Limits": "Employee limit: Up to Rs 5 Lakhs (In certain cases, employees are given discount if bidding amount is upto Rs. 2 lakhs)If applying as RII: Upto Rs. 2 lakhsIf applying as NII: Above Rs. 2 lakhs",
      "Bidding at Cut-off Price Allowed": "Yes for Employee and RII/NII"
    }
  ],
  "anchor_investors": [
    [
      "Bid Date",
      "February 7, 2025"
    ],
    [
      "Shares Offered",
      "18,48,800"
    ],
    [
      "Anchor Portion Size (In Cr.)",
      "29.40"
    ],
    [
      "Anchorlock-in periodend date for 50% shares (30 Days)",
      "March 14, 2025"
    ],
    [
      "Anchor lock-in period end date for remaining shares (90 Days)",
      "May 13, 2025"
    ]
  ],
  "timeline": [
    [
      "IPO Open Date",
      "Mon, Feb 10, 2025"
    ],
    [
      "IPO Close Date",
      "Wed, Feb 12, 2025"
    ],
    [
      "Tentative Allotment",
      "Thu, Feb 13, 2025"
    ],
    [
      "Initiation of Refunds",
      "Fri, Feb 14, 2025"
    ],
    [
      "Credit of Shares to Demat",
      "Fri, Feb 14, 2025"
    ],
    [
      "Tentative Listing Date",
      "Mon, Feb 17, 2025"
    ],
    [
      "Cut-off time for UPI mandate confirmation",
      "5 PM onFebruary 12, 2025"
    ]
  ],
  "lots": [
    {
      "Application": "Retail (Min)",
      "Lots": "1",
      "Shares": "800",
      "Amount": "₹1,27,200"
    },
    {
      "Application": "Retail (Max)",
      "Lots": "1",
      "Shares": "800",
      "Amount": "₹1,27,200"
    },
    {
      "Application": "HNI (Min)",
      "Lots": "2",
      "Shares": "1,600",
      "Amount": "₹2,54,400"
    }
  ],
  "promoters_holdings": [
    [
      "Share Holding Pre Issue",
      "69.96%"
    ],
    [
      "Share Holding Post Issue",
      "49.20%"
    ]
  ],
  "company_financials": [
    [
      "Period Ended",
      "31 Dec 2024",
      "31 Mar 2024",
      "31 Mar 2023",
      "31 Mar 2022"
    ],
    [
      "Assets",
      "170.06",
      "128.86",
      "97.83",
      "81.23"
    ],
    [
      "Total Income",
      "167.99",
      "177.96",
      "137.03",
      "119.92"
    ],
    [
      "Profit After Tax",
      "17.42",
      "16.36",
      "3.59",
      "-1.09"
    ],
    [
      "Net Worth",
      "",
      "41.09",
      "27.3",
      "23.93"
    ],
    [
      "Reserves and Surplus",
      "34.31",
      "21.16",
      "7.37",
      "4"
    ],
    [
      "Total Borrowing",
      "51.92",
      "42.01",
      "21.36",
      "16.58"
    ],
    [
      "Amount in ₹ Crore"
    ]
  ],
  "KPI": [
    {
      "KPI": "ROE",
      "Values": "47.50%"
    },
    {
      "KPI": "ROCE",
      "Values": "35.20%"
    },
    {
      "KPI": "Debt/Equity",
      "Values": "1.02"
    },
    {
      "KPI": "RoNW",
      "Values": "39.54%"
    },
    {
      "KPI": "PAT Margin",
      "Values": "9.26%"
    },
    {
      "KPI": "Price to Book Value",
      "Values": "7.73"
    }
  ],
  "EPS": [
    {
      "": "EPS (Rs)",
      "Pre IPO": "8.18",
      "Post IPO": "9.50"
    },
    {
      "": "P/E (x)",
      "Pre IPO": "19.44",
      "Post IPO": "16.74"
    }
  ],
  "listing_details": [
    [
      "Listing Date",
      "February 17, 2025"
    ],
    [
      "BSE Script Code",
      ""
    ],
    [
      "NSE Symbol",
      "CHANDAN"
    ],
    [
      "ISIN",
      "INE0B2N01016"
    ],
    [
      "Final Issue Price",
      "₹159 per share"
    ],
    [
      "NSE Listing Group",
      "ST"
    ]
  ],
  "listing_day_trading": [
    {
      "Price Details": "Final Issue Price",
      "NSE SME": "₹159.00"
    },
    {
      "Price Details": "Open",
      "NSE SME": "₹165.10"
    },
    {
      "Price Details": "Low",
      "NSE SME": "₹165.10"
    },
    {
      "Price Details": "High",
      "NSE SME": "₹173.35"
    },
    {
      "Price Details": "Last Trade",
      "NSE SME": "₹173.35"
    }
  ],
  "review": [
    {
      "Review By": "Brokers",
      "Subscribe": "1",
      "Neutral": "0",
      "Avoid": "0"
    },
    {
      "Review By": "Members",
      "Subscribe": "0",
      "Neutral": "0",
      "Avoid": "0"
    }
  ],
  "bidding_details": [
    {
      "Category": "QIB",
      "Subscription (times)": "7.58",
      "Shares Offered": "12,33,600",
      "Shares bid for": "93,56,800",
      "Total Application": "12"
    },
    {
      "Category": "NII*",
      "Subscription (times)": "18.85",
      "Shares Offered": "9,25,600",
      "Shares bid for": "1,74,52,000",
      "Total Application": "457"
    },
    {
      "Category": "Retail",
      "Subscription (times)": "2.44",
      "Shares Offered": "21,59,200",
      "Shares bid for": "52,72,800",
      "Total Application": "6,591"
    },
    {
      "Category": "Total",
      "Subscription (times)": "7.04",
      "Shares Offered": "45,64,000",
      "Shares bid for": "3,21,32,800",
      "Total Application": "7,099"
    }
  ],
  "prospectus_links": [
    {
      "title": "Chandan Healthcare IPO DRHP",
      "href": "https://nsearchives.nseindia.com/emerge/corporates/content/Registration_29092024183445_DRHP.pdf",
      "text": "Chandan Healthcare IPODRHP"
    },
    {
      "title": "Chandan Healthcare IPO RHP",
      "href": "https://www.sebi.gov.in/filings/public-issues/feb-2025/chandan-healthcare-limited_92166.html",
      "text": "Chandan Healthcare IPORHP"
    },
    {
      "title": "Chandan Healthcare IPO Final Prospectus",
      "href": "https://nsearchives.nseindia.com/emerge/corporates/content/ChandanHealthcareLimited_PROSP.pdf",
      "text": "Chandan Healthcare IPOFinal Prospectus"
    }
  ],
  "promoters": "The Company's Promoters are Amaranita Holdings (India) Private Limited, Amar Singh, Asmita Singh, Alok Singh, Shaleen Solanki, Vijay Singh and Vinay Lamba.",
  "company_contact_details": {
    "company_name": "Chandan Healthcare Ltd.",
    "address": "Biotech Park, Sector G,, Jankipuram,, Kursi Road,, Lucknow, ,, Uttar Pradesh, , 226021, Phone, :, Email, :, Website, :",
    "phone": "+91 8429024430",
    "email": "secretarial@chandan.co.in",
    "website": "https://www.chandandiagnostic.com/"
  },
  "ipo_registrar_details": {
    "name": "Kfin Technologies Ltd.",
    "phone": "04067162222",
    "email": "chl.ipo@kfintech.com",
    "website": "https://ipostatus.kfintech.com/"
  },
  "about_company": {
    "description": "Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centres in North India with pathology and radiology testing services. As of December 31, 2024, the company operates one flagship laboratory, seven central laboratories, and twenty-six satellite centres, with over three hundred collection centres in more than 23 cities across Uttar Pradesh and over 19 in Uttarakhand. As of December 31, 2024, the company offers 1,496 tests across different specialities. The test menu includes The radiology facilities have eleven CT scanners and four MRI machines. As of December 31, 2024, the company employed 15 radiologists, 23 pathologists, and over 161 other qualified professionals. Products and services: The company primarily provides diagnostic services and ad hoc sales of consumables like X-ray films and reagents. Its subsidiary, Chandan Pharmacy Limited, operates medical stores offering a range of pharmaceutical products. Competitive Strength:",
    "competitive_strengths": [
      "481 routine pathology tests in basic biochemistry and haematology, plus 1,015 specialised tests like immunohistopathology and molecular pathology, and",
      "545 radiology tests, including x-rays, ultrasonography, CT, MRI, and specialised CT scans."
    ]
  },
  "ipo_lead_managers": [
    {
      "name": "Unistone Capital Pvt.Ltd.",
      "profile_link": "/report/ipo-lead-manager-review/112/176/",
      "title": "About Unistone Capital Pvt.Ltd."
    }
  ],
  "listing_gain_percent": "3.84%"
}